The ALS Association, ALS Finding a Cure, and the Northeast ALS Consortium Issue Request for Proposals for Phase II Clinical Development of Novel, High-Potential Treatments for ALS
The ALS Association, ALS Finding a Cure, and the Northeast ALS Consortium Issue Request for Proposals for Phase II Clinical Development of Novel, High-Potential Treatments for ALS
ALS ACT and the Northeast ALS Consorrtium (NEALS) are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in Amyotrophic Lateral Sclerosis. The call for clinical study proposals is intended for academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of the Northeast ALS Consortium (NEALS), and ALS scientists throughout the world. Up to USD $1,500,000 (10% indirect costs can be included in this amount) in ALS ACT clinical research support is available.
Deadlines:
Letter of Intent: November 30, 2015
Notification to submit full application: December 16, 2015
Full Application: February 1, 2016
For more information please go to: http://www.alsa.org/news/media/press-releases/request-for-proposals.html
